Henriette E. Meyer zu Schwabedissen
发表
H. E. Meyer zu Schwabedissen,
K. Brecht,
A. M. Schäfer,
2020,
Cancers.
G. Homuth,
H. Kroemer,
J. Mostertz,
2006,
Shock.
H. E. Meyer zu Schwabedissen,
S. Oswald,
M. Grube,
2020,
Molecular pharmaceutics.
H. Völzke,
S. Baumeister,
H. Wallaschofski,
2015,
Pharmacogenetics and genomics.
R. Vasan,
H. Völzke,
S. Felix,
2014,
European heart journal.
P. Elliott,
Toshiko Tanaka,
S. Bandinelli,
2011,
Circulation.
H. Kroemer,
H. E. Meyer zu Schwabedissen,
M. Grube,
2005,
Drug metabolism reviews.
R. Kim,
H. E. Meyer zu Schwabedissen,
R. Tirona,
2008,
Cancer research.
H. E. Meyer zu Schwabedissen,
S. Neuhoff,
M. Piquette-Miller,
2022,
Pharmaceutics.
H. E. Meyer zu Schwabedissen,
A. Fuchs,
I. Seibert,
2021,
Drug metabolism and pharmacokinetics.
M. Liechti,
H. E. Meyer zu Schwabedissen,
P. Vizeli,
2016,
Pharmacogenetics and genomics.
R. Kim,
H. Kroemer,
H. E. Meyer zu Schwabedissen,
2010,
American journal of physiology. Renal physiology.
A. Schmidt,
Timo Glatter,
J. Huwyler,
2016,
Molecular pharmaceutics.
H. Kroemer,
C. Fusch,
H. E. Meyer zu Schwabedissen,
2007,
Drug Metabolism and Disposition.
S. Krämer,
H. E. Meyer zu Schwabedissen,
D. Müller,
2022,
Pharmaceutics.
H. E. Meyer zu Schwabedissen,
J. Huwyler,
M. Hamburger,
2020,
Bioconjugate chemistry.
C. Lengerke,
H. E. Meyer zu Schwabedissen,
Fabiola Porta,
2018,
Molecular pharmaceutics.
K. Schmitz,
K. Sternberg,
J. Hussner,
2014,
Molecular pharmaceutics.
H. Kroemer,
K. Schmitz,
N. Grabow,
2013,
Journal of Materials Science: Materials in Medicine.
H. E. Meyer zu Schwabedissen,
K. Hersberger,
C. Jeiziner,
2021,
Clinical and translational science.
H. E. Meyer zu Schwabedissen,
K. Hersberger,
Markus L Lampert,
2021,
Pharmacogenomics and personalized medicine.
K. Brouwer,
R. Evers,
Shuiying Hu,
2022,
Clinical pharmacology and therapeutics.
H. Kroemer,
H. E. Meyer zu Schwabedissen,
Henriette E. Meyer zu Schwabedissen,
2011,
Handbook of experimental pharmacology.
C. Gieger,
G. Abecasis,
L. Kiemeney,
2014,
PLoS genetics.
Henry Völzke,
Till Ittermann,
Matthias Nauck,
2012,
Thyroid : official journal of the American Thyroid Association.
H. Kroemer,
T. Budde,
H. E. Meyer zu Schwabedissen,
2017,
Biochemical pharmacology.
S. Krähenbühl,
H. E. Meyer zu Schwabedissen,
J. Huwyler,
2020,
Clinical pharmacology and therapeutics.
J. Drewe,
H. E. Meyer zu Schwabedissen,
Simon Nicolussi,
2019,
British journal of pharmacology.
H. E. Meyer zu Schwabedissen,
O. Potterat,
A. M. Schäfer,
2018,
Molecular Pharmacology.
Bradley L Urquhart,
R. Kim,
H. E. Meyer zu Schwabedissen,
2010,
Circulation research.
H. E. Meyer zu Schwabedissen,
Celio Ferreira,
Ramona Meyer,
2019,
Biochimica et biophysica acta. Gene regulatory mechanisms.
H. E. Meyer zu Schwabedissen,
M. Grube,
P. Hagen,
2018,
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
L. Bierut,
J. Nurnberger,
H. Völzke,
2017,
Molecular Psychiatry.
H. E. Meyer zu Schwabedissen,
I. Seibert,
Fabiola Porta,
2019,
Materials.
W. Hoffmann,
S. Felix,
M. Nauck,
2012,
The Journal of Biological Chemistry.
H. E. Meyer zu Schwabedissen,
T. Mikoteit,
M. Hatzinger,
2021,
International journal of molecular sciences.
C. Gieger,
H. Völzke,
C. Meisinger,
2012,
Human molecular genetics.
H. E. Meyer zu Schwabedissen,
A. M. Schäfer,
M. Grube,
2021,
Pharmaceutics.
S. Krähenbühl,
H. E. Meyer zu Schwabedissen,
U. Duthaler,
2019,
Molecular Pharmacology.
Samuel S. Allemann,
Samuel S Allemann,
H. E. Meyer zu Schwabedissen,
2023,
Journal of personalized medicine.
H. Kroemer,
H. E. Meyer zu Schwabedissen,
M. Grube,
2011,
Expert review of clinical pharmacology.
H. E. Meyer zu Schwabedissen,
V. Malagnino,
J. Hussner,
2019,
American journal of physiology. Gastrointestinal and liver physiology.
H. E. Meyer zu Schwabedissen,
T. Bock,
A. M. Schäfer,
2018,
Molecular pharmaceutics.
Expression of OATP2B1 as determinant of drug effects in the microcompartment of the coronary artery.
H. E. Meyer zu Schwabedissen,
J. Hussner,
D. Gliesche,
2015,
Vascular pharmacology.
H. Kroemer,
I. Cascorbi,
C. Fusch,
2005,
Drug Metabolism and Disposition.
W. Hoffmann,
C. Havemann,
H. Kroemer,
2015,
Neuro-oncology.
U. John,
H. Völzke,
K. Hegenscheid,
2016,
Human brain mapping.
H. E. Meyer zu Schwabedissen,
M. Al-Ibrahim,
J. Dingemanse,
2021,
Clinical pharmacology and therapeutics.
H. E. Meyer zu Schwabedissen,
T. Einfalt,
J. Huwyler,
2019,
eLife.
H. Kroemer,
J. Rollnik,
H. E. Meyer zu Schwabedissen,
2014,
BMC Research Notes.
H. Völzke,
H. Grabe,
S. Van der Auwera,
2023,
International journal of molecular sciences.
R. Kim,
H. Glaeser,
D. Kroetz,
2010,
Pharmacogenetics and genomics.
M. Zygmunt,
N. Endlich,
H. Fluhr,
2013,
Molecular human reproduction.
H. E. Meyer zu Schwabedissen,
V. Butterweck,
K. Brecht,
2022,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
H. Kroemer,
H. E. Meyer zu Schwabedissen,
C. Rimmbach,
2014,
American journal of physiology. Renal physiology.
H. E. Meyer zu Schwabedissen,
I. Seibert,
V. Malagnino,
2018,
Biochemical pharmacology.
H. Kroemer,
H. E. Meyer zu Schwabedissen,
U. Schwarz,
2014,
Diabetes.
R. Kim,
H. Kroemer,
E. Schuetz,
2010,
Hepatology.
Markus Grube,
H. Kroemer,
C. Fusch,
2005,
The American journal of pathology.
Samuel S. Allemann,
R. Tilen,
Henriette E. Meyer zu Schwabedissen,
2024,
Archives of Disease in Childhood.
Samuel S. Allemann,
Samuel S Allemann,
H. E. Meyer zu Schwabedissen,
2022,
Frontiers in Psychiatry.
Samuel S. Allemann,
Samuel S Allemann,
H. E. Meyer zu Schwabedissen,
2021,
Trials.
H. E. Meyer zu Schwabedissen,
T. Mikoteit,
M. Hatzinger,
2021,
Life.
Samuel S. Allemann,
Samuel S Allemann,
H. E. Meyer zu Schwabedissen,
2022,
Pharmacy.
K. Mizuguchi,
R. Kim,
Y. Mokrab,
2011,
Pharmacogenetics and genomics.
R. Kim,
H. E. Meyer zu Schwabedissen,
U. Schwarz,
2017,
Histochemistry and Cell Biology.
Samuel S. Allemann,
K. Hersberger,
C. Jeiziner,
2023,
Pharmacogenomics.
H. E. Meyer zu Schwabedissen,
M. Grube,
Jonny Kinzi,
2021,
Biochemical pharmacology.
H. Völzke,
D. Janowitz,
H. Grabe,
2020,
Scientific Reports.
M. Hamburger,
I. Seibert,
Jonny Kinzi,
2023,
British journal of pharmacology.
H. E. Meyer zu Schwabedissen,
U. Zimmermann,
J. Hussner,
2016,
OncoTargets and therapy.
Samuel S. Allemann,
Samuel S Allemann,
H. E. Meyer zu Schwabedissen,
2022,
Pharmacogenomics and personalized medicine.
M. Liechti,
H. E. Meyer zu Schwabedissen,
P. Vizeli,
2017,
European Journal of Clinical Pharmacology.
H. E. Meyer zu Schwabedissen,
T. Mikoteit,
M. Hatzinger,
2020,
Pharmacogenomics.
R. Kim,
H. E. Meyer zu Schwabedissen,
Richard B Kim,
2009,
Molecular pharmaceutics.
S. Krähenbühl,
H. E. Meyer zu Schwabedissen,
U. Duthaler,
2021,
British journal of clinical pharmacology.